Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors.
Antineoplastic Agents
/ chemical synthesis
Cell Cycle
/ drug effects
Cell Proliferation
/ drug effects
Cells, Cultured
Dose-Response Relationship, Drug
Drug Design
Drug Screening Assays, Antitumor
Furans
/ chemical synthesis
HeLa Cells
Healthy Volunteers
Humans
Molecular Structure
Polymerization
/ drug effects
Structure-Activity Relationship
Tubulin
/ metabolism
Tubulin Modulators
/ chemical synthesis
Benzo[b]furan
Colchicine binding site
Inhibition tubulin assembly
In vivo activity
Microtubules
Journal
European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510
Informations de publication
Date de publication:
15 Aug 2020
15 Aug 2020
Historique:
received:
17
02
2020
revised:
09
05
2020
accepted:
09
05
2020
pubmed:
18
5
2020
medline:
5
2
2021
entrez:
18
5
2020
Statut:
ppublish
Résumé
A new class of inhibitors of tubulin polymerization based on the 2-amino-3-(3',4',5'-trimethoxybenzoyl)benzo[b]furan molecular scaffold was synthesized and evaluated for in vivo and in vitro biological activity. These derivatives were synthesized with different electron-releasing or electron-withdrawing substituents at one of the C-4 through C-7 positions. Methoxy substitution and location on the benzene part of the benzo[b]furan ring played an important role in affecting antiproliferative activity, with the greatest activity occurring with the methoxy group at the C-6 position, the least with the substituent at C-4. The same effect was also observed with ethoxy, methyl or bromine at the C-6 position of the benzo[b]furan skeleton, with the 6-ethoxy-2-amino-3-(3',4',5'-trimethoxybenzoyl)benzo[b]furan derivative 4f as the most promising compound of the series. This compound showed remarkable antiproliferative activity (IC
Identifiants
pubmed: 32417696
pii: S0223-5234(20)30419-0
doi: 10.1016/j.ejmech.2020.112448
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Furans
0
Tubulin
0
Tubulin Modulators
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
112448Informations de copyright
Copyright © 2020 Elsevier Masson SAS. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.